Activities
-
Consulting
JD consults with all sizes of public and private companies, universities and charities and also CROs.
These include retained consultancies, ad hoc consultancies and scientific board memberships.
-
Non-exec directorships
JD is a non executive director of Xenogesis and Sentinel Oncology. He is also director of INMED.
-
Drug Design and Drug Discovery
JD works with companies at all stages of drug design, drug discovery and early drug development covering:
- All aspects from target selection via CD nomination to early clinical studies.
- Advice on strategy and tactics as well as milestone definition and transition reviews.
- Specific focus on individual projects and advice on portfolio and pipeline issues.
- Portfolio and pipeline reviews.
-
Licencing and alliances
JD works with companies on all aspects of:
- Partner identification, collaboration selection, licencing evaluation, negotiation, participation in inward and outward licencing.
- Definition and management of Research Collaborations and project and supervisory levels.
- Due diligence both direct and third party.
-
Outsourcing
JD advises on selection of suitable CROs as well as definitions of contracts and management of interactions.
The overwhelming objective is the identification of positive cost benefit solutions.
-
Intellectual Property and Patenting
Patent strategy definition, patent analysis and due diligence, litigation and expert witnessing.